⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 29, 2001CirculationOpen Access

Monitoring Platelet Function in Glycoprotein IIb/IIIa Inhibitor Therapy

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

KWKenneth K. WuIllinois College

James T. WillersonSemmelweis University

Discussion

Loading...

Member takes

Implication

Discusses the mechanistic role of GP IIb/IIIa receptors in platelet aggregation and their importance as targets for antithrombotic therapy.

Structured PICO

I

Intervention

Glycoprotein IIb/IIIa Inhibitor Therapy

Discusses the mechanistic role of GP IIb/IIIa receptors in platelet aggregation and their importance as targets for antithrombotic therapy.

Cite This Study

Wu et al. (2001) studied this question.

synapsesocial.com/papers/6a925e28ec33462ec0f0d18b https://doi.org/10.1161/01.cir.103.21.2528

Topics

Dual antiplatelet therapy

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Glycoprotein IIb/IIIa Integrin Blockade1998 · 120 citations
2Testing Platelet Activation With a Shear-Dependent Platelet Function Test Versus Aggregation-Based Tests2001 · 51 citations
3Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention2001 · 359 citations
4Clinical Outcomes of Therapeutic Agents That Block the Platelet Glycoprotein IIb/IIIa Integrin in Ischemic Heart Disease1998 · 351 citations
5A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary Thrombosis1996 · 693 citations